Diuretic Versus Placebo in Pulmonary Embolism
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 270 participants.
Also called NCT02268903
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 270 participants
- Registry
-
NCT02268903
-
- Other papers using this trial's data
- Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT02268903. Randomized; quadruple masking; primary purpose treatment. Start 2015-04-13 (actual); primary completion 2018-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Diuretic Versus Placebo in Pulmonary Embolism
- Acronym
- DiPER
- Condition
- Pulmonary Embolism With Right Ventricle Enlargement
- Intervention (Drug)
- Diuretics : Furosemide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct02268903- Content hash
ab83892986a15005fa6bf7d52975bddd15f4d7b465ab2212020780ec587b0b96